Clinic-based depression screening in hepatocellular carcinoma patients using the PHQ-9 depression questionnaire
10.3760/cma.j.issn.1674-6554.2016.07.016
- VernacularTitle:患者健康问卷抑郁量表在肝癌患者中的应用
- Author:
Jing ZHANG
;
Songlin AN
;
Liming WANG
;
Weiqi RONG
;
Fan WU
;
Li FENG
;
Jianxiong WU
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
PHQ-9;
Depression
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2016;25(7):646-649
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the possibility of perform depression screening with the patient health questionnaire (PHQ-9) in hepatocellular carcinoma patients,and to evaluate the prevalence of depression among these patients.Methods 186 hepatocellular carcinoma patients completed PHQ-9 and Hamilton depression scale (HAMD) from January 2015 to April 2015.60 patients randomly selected from these 186 patients received depression screening again with PHQ-9 in 7 to 14 days after the first survey.Results Cronbach's α coefficient of PHQ-9 was 0.869,the test-retest reliability 0.963,and the range of correlation coefficient of the nine items with the total score of the scale was 0.546-0.752 (P＜0.01).The sensitivity and specificity of PHQ-9 were 84.4％ and 95.7％ respectively.69(37.1％) cases of the 186 patients were detected with depression with PHQ-9,and mild,moderate and major depression were 41 (22.0％),21 (11.3％) and 7(3.8％) respectively.Conclusion PHQ-9 has been shown to have good reliability and validity for screening of depression in hepatocellular carcinoma patients.
